2. Spółki
  3. Raporty Spółek ESPI/EBI

Raporty Spółek ESPI/EBI

Invitation and materials for a General shareholders meeting SOPHARMA AD (BG11SOSOBT18)

25-09-2026 14:17:57 | ESPI | 286/2026
oUNI-EN: Invitation and materials for a General shareholders meeting

 PAP
Data: 2026-09-25
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • SFA_286_EGM_30102026.rar
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 286 / 2026
    Date of issue: 2026-09-25
    Short name of the issuer
    SOPHARMA AD
    Subject
    Invitation and materials for a General shareholders meeting
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    Publication of materials
    for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for October 30, 2026 and in the absence of a quorum on this date - for November 20, 2026
    Sofia, Bulgaria, September 25, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of "Sopharma" AD _SFA: "BSE" AD, SPH: Warsaw Stock Exchange_ presents the following materials on the agenda of EGM convened for October 30, 2026 and in the absence of a quorum on this date - for November 20, 2026, to the attention of shareholders, which will be available on the website of Extri News _www.x3news.com_, in the FSC system, on the Company's website https://www.sopharmagroup.com/bg/investitori/korporativni-sabitia/obshto-sabranie-na-aktsionerite and on the website www.investor.bg, as well as in hard copy at the address of the Company:
    1. Minutes of a meeting of the Board of Directors for convening an Extraordinary Meeting of Shareholders of "Sopharma" AD;
    2. Invitation to convene the Extraordinary General Meeting of Shareholders _EGM_ of "Sopharma" AD;
    3. Power of attorney - an example for representing a shareholder at the EGM;
    4. Declaration for voting by correspondence - an example for the EGM;
    5. For item 1 of the agenda: Approval of the 6-month financial report for the first half of 2026- is already available on the website of Extri News _www.x3news.bg_, in the FSC system, on the company's website and on the website www.investor.bg;
    6. For item 2 of the agenda: Approval of a decision under Article 30, paragraphs 5-7 of the Company's Articles of Association for the distribution of profit and payment of an interim dividend based on the adopted 6-month financial report;
    7. For item 3 of the agenda: Election of a registered auditor to perform a mandatory assurance engagement regarding the sustainability of the consolidated sustainability report of "Sopharma" AD for 2026, if applicable.
    Annexes
    File Description
    SFA_286_EGM_30102026.rar Invitation and materials for a General shareholders meeting

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Additional regulated information required to be disclosed under the laws of a Member State
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission New _to be used for new information_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2026-10-30
    Date or period covered [Date or end of the period to which the information relates] 2026-10-30
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    097900BGGW0000048796
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    097900BGGW0000048796 Large undertaking _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-09-25 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Invitation and materials for a General shareholders meeting
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia 2026-09-25
    Rok biezacy 2026
    Numer 286
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.